Delivery Order SPE2DB24D2003-SPE2DB25FXNF0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 50 mg tablets (60-count units) under a firm fixed-price contract valued at $2,538.23. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $5,579.94 delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a $5,802.87 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Briviact 100 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $3,833.56 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, a pharmaceutical product. The contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizing firm fixed pricing with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a $2,786.07 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Briviact 100 mg tablets (60 count). This contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This award represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Briviact 100 mg tablets (60-count units) under a firm fixed-price contract valued at $2,885.81. This is a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for 60-tablet units of Briviact 100 mg tablets with a ceiling value of $6,386.97. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under the company's larger indefinite delivery contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.15 delivery order on August 18, 2025, for Briviact 75 mg tablets (60-count units) through a firm fixed-price contract with an ultimate completion date of August 19, 2025. The award is non-set-aside and competitively awarded, with performance to take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,789.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Briviact 50 mg tablets (60-count package). The contract, which is classified as a child award under a larger vehicle, carries an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation,...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXNF0Delivery Order
The Defense Logistics Agency awarded a $2,905.07 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent IDC functions as a global pharmaceutical support vehicle enabling the company to serve federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/26/25 |